March 12, 2009

HELIX BIOPHARMA FORM 20-F REGISTRATION STATEMENT DECLARED EFFECTIVE BY SEC (PDF)

(AURORA, Ontario) – Helix BioPharma Corp. (TSX, FSE: “HBP”) announced that its registration statement on Form 20-F has been declared effective by the U.S. Securities and Exchange Commission (“SEC”).